Suppr超能文献

间充质干细胞治疗多器官受累的新冠肺炎患者。

Mesenchymal stem cells treatment in COVID-19 patient with multi-organ involvement.

作者信息

Yilmaz R, Adas G, Cukurova Z, Kart Yasar K, Isiksacan N, Oztel O N, Karaoz E

出版信息

Bratisl Lek Listy. 2020;121(12):847-852. doi: 10.4149/BLL_2020_139.

Abstract

The aim of this study is to evaluate the therapeutic effect of mesenchymal stem cells (MSCs) in a severe case of brain and multiple organ involvement in a patient with COVID-19. Here, a 51-year-old male patient with multi-organ involvement due to COVID-19 infection and developing cardiac arrest is presented. MSCs were transplanted to the patient four times systematically and once intrathecally. As a result, the application of MSCs has been found to have a healing effect on organs in this patient with severe COVID-19 infection. In addition, transplantation of MSCs both systematically and intrathecally is considered to be effective in the treatment of the central nervous system (Tab. 2, Fig. 2, Ref. 24). Keywords: mesenchymal stem cell, COVID-19, organ involvement.

摘要

本研究的目的是评估间充质干细胞(MSCs)对一名新冠肺炎多器官受累重症患者的治疗效果。在此,我们报告一名51岁男性患者,因感染新冠肺炎出现多器官受累并发生心脏骤停。间充质干细胞分四次系统性地和一次鞘内注射移植到该患者体内。结果发现,间充质干细胞的应用对这名重症新冠肺炎感染患者的器官具有治愈作用。此外,系统性和鞘内注射间充质干细胞被认为对中枢神经系统的治疗有效(表2,图2,参考文献24)。关键词:间充质干细胞,新冠肺炎,器官受累

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验